“Das PSMA-PET/CT soll bei allen Patienten mit biochemischem Progress nach radikaler Prostatektomie für eine frühe Tumordetektion eingesetzt werden.”

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • Jörg Kotzerke - , Department of Nuclear Medicine (Author)
  • Dirk Böhmer - (Author)
  • Thorsten Schlomm - (Author)
  • Thomas Maurer - (Author)
  • Ambros J Beer - (Author)
  • Heinz Schmidberger - (Author)

Abstract

The debate refers the known evidence for PSMA-PET/CT in biochemical recurrence of prostate cancer and consider carefully interdisciplinary in which situation which patient needs imaging to choose the adequate therapeutic option. General aspects for the care of cancer patients are taken into consideration.

Translated title of the contribution
PSMA-PET/CT has to be performed in every patient with biochemical recurrence following radical prostatectomy for early tumor detection

Details

Original languageGerman
Pages (from-to)69-73
Number of pages5
JournalNuklearmedizin
Volume57
Issue number3
Publication statusPublished - Jun 2018
Peer-reviewedYes

External IDs

Scopus 85058904197

Keywords

Sustainable Development Goals

Keywords

  • Antigens, Surface/metabolism, Early Detection of Cancer/methods, Edetic Acid/analogs & derivatives, Gallium Isotopes, Gallium Radioisotopes, Glutamate Carboxypeptidase II/metabolism, Humans, Male, Neoplasm Recurrence, Local/diagnostic imaging, Oligopeptides, Positron Emission Tomography Computed Tomography/methods, Prostatic Neoplasms/diagnostic imaging, Radiopharmaceuticals

Library keywords